CTEV
Claritev Corporation
Price Chart
Latest Quote
$29.42
-0.33 (-1.11%)
Current Price
| Previous Close | $29.75 |
| Open | $30.30 |
| Day High | $30.61 |
| Day Low | $29.03 |
| Volume | 180,825 |
Stock Information
| Shares Outstanding | 17.05M |
| Total Debt | $4.74B |
| Cash Equivalents | $21.33M |
| Revenue | $978.76M |
| Net Income | $-286.52M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $501.55M |
| EPS (TTM) | $-17.33 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.22B |
| Sales | $978.76M |
| Income | $-286.52M |
| Book/sh | $-14.18 |
| Cash/sh | $1.25 |
| Employees | 3K |
Financial Ratios
| Quick Ratio | 0.93 |
| Current Ratio | 1.28 |
Returns & Margins
| ROA | 1.10% |
| Gross Margin | 73.23% |
| Operating Margin | 7.55% |
| Profit Margin | -29.27% |
Ownership
| Insider Ownership | 7.45% |
| Institutional Ownership | 91.03% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.30 |
| P/S | 0.51 |
| P/B | -2.07 |
Analyst Data
| Recommendation | none |
| Target Price | $36.83 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 63.69 |
| ATR | nan |
| Shares Float | 5.76M |
| Short Float | 11.30% |
| Short Ratio | 5.58 |
| Volatility | 0.77 |
| Rel Volume | 1.55 |
Performance History
| Week | -8.15% |
| Month | +81.60% |
| Quarter | +91.79% |
| 6 Months | -23.29% |
| YTD | -13.19% |
| Year | -26.87% |
| 3 Years | -57.97% |
| 5 Years | -91.78% |
| 10 Years | -92.43% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $29.42 | 180,800 |
| 2026-06-17 | $29.75 | 95,700 |
| 2026-06-16 | $30.67 | 72,100 |
| 2026-06-15 | $30.61 | 94,200 |
| 2026-06-12 | $30.89 | 128,000 |
| 2026-06-11 | $32.03 | 111,300 |
| 2026-06-10 | $29.74 | 82,900 |
| 2026-06-09 | $28.35 | 67,400 |
| 2026-06-08 | $27.07 | 90,100 |
| 2026-06-05 | $25.84 | 86,500 |
| 2026-06-04 | $27.57 | 99,900 |
| 2026-06-03 | $26.27 | 109,900 |
| 2026-06-02 | $28.34 | 131,100 |
| 2026-06-01 | $26.99 | 151,800 |
| 2026-05-29 | $25.12 | 117,600 |
| 2026-05-28 | $24.56 | 72,700 |
| 2026-05-27 | $23.07 | 133,000 |
| 2026-05-26 | $21.76 | 126,800 |
| 2026-05-22 | $21.67 | 147,900 |
| 2026-05-21 | $23.55 | 228,600 |
| 2026-05-20 | $21.24 | 372,100 |
| 2026-05-19 | $16.20 | 207,800 |
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
đ° Latest News
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View
Simply Wall St. âĸ 2026-06-11T18:06:56Z
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires âĸ 2026-05-18T20:01:00ZSector Update: Healthcare Stocks Advance Monday Afternoon
MT Newswires âĸ 2026-05-18T17:57:12ZClaritev Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T23:03:50Z
Claritev Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T20:45:42Z
Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-07T11:10:03Z
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
Zacks âĸ 2026-05-06T22:30:20Z
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-05T22:05:17Z
How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay Positive
Simply Wall St. âĸ 2026-05-05T08:07:40Z
Claritev Stockholders OK Directors, PwC and Pay Plan at 2026 Virtual Annual Meeting
MarketBeat âĸ 2026-05-02T06:08:26Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $313,339,000 | $299,086,000 | $289,851,000 | $197,731,000 |
| Cost Of Revenue | $316,367,000 | $303,450,000 | $295,620,000 | $204,098,000 |
| Total Revenue | $965,413,000 | $930,624,000 | $961,524,000 | $1,079,716,000 |
| Operating Revenue | $965,413,000 | $930,624,000 | $961,524,000 | $1,079,716,000 |
| Expenses | ||||
| Interest Expense | $392,022,000 | $326,371,000 | $333,208,000 | $303,401,000 |
| Total Expenses | $920,355,000 | $822,368,000 | $790,603,000 | $745,534,000 |
| Other Income Expense | $-27,675,000 | $-1,555,727,000 | $46,994,000 | $-595,024,000 |
| Net Non Operating Interest Income Expense | $-390,461,000 | $-323,241,000 | $-324,975,000 | $-299,901,000 |
| Interest Expense Non Operating | $392,022,000 | $326,371,000 | $333,208,000 | $303,401,000 |
| Operating Expense | $603,988,000 | $518,918,000 | $494,983,000 | $541,436,000 |
| General And Administrative Expense | $158,562,000 | $86,845,000 | $74,966,000 | $132,144,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Net Interest Income | $-390,461,000 | $-323,241,000 | $-324,975,000 | $-299,901,000 |
| Interest Income | $1,561,000 | $3,130,000 | $8,233,000 | $3,500,000 |
| Normalized Income | $-263,193,650 | $-200,560,617 | $-131,947,409 | $-102,843,040 |
| Net Income From Continuing And Discontinued Operation | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Total Operating Income As Reported | $28,765,000 | $-1,389,931,000 | $161,982,000 | $-362,732,000 |
| Net Income Common Stockholders | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Net Income | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Net Income Including Noncontrolling Interests | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Net Income Continuous Operations | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Pretax Income | $-373,078,000 | $-1,770,712,000 | $-107,060,000 | $-560,743,000 |
| Special Income Charges | $-25,008,000 | $-1,556,204,000 | $45,029,000 | $-662,363,000 |
| Interest Income Non Operating | $1,561,000 | $3,130,000 | $8,233,000 | $3,500,000 |
| Operating Income | $45,058,000 | $108,256,000 | $170,921,000 | $334,182,000 |
| Depreciation Amortization Depletion Income Statement | $445,426,000 | $432,073,000 | $420,017,000 | $409,292,000 |
| Depreciation And Amortization In Income Statement | $445,426,000 | $432,073,000 | $420,017,000 | $409,292,000 |
| Amortization Of Intangibles Income Statement | $343,757,000 | $343,883,000 | $342,694,000 | $340,536,000 |
| Depreciation Income Statement | $101,669,000 | $88,190,000 | $77,323,000 | $68,756,000 |
| Gross Profit | $649,046,000 | $627,174,000 | $665,904,000 | $875,618,000 |
| Per Share | ||||
| Diluted EPS | $-17.30 | $-101.92 | $-5.69 | $-36.00 |
| Basic EPS | $-17.30 | $-101.92 | $-5.69 | $-36.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $-6,586,650 | $-110,456,617 | $6,743,591 | $-124,955,040 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $495,073,000 | $547,823,000 | $604,940,000 | $753,341,000 |
| Total Unusual Items | $-27,675,000 | $-1,555,727,000 | $46,994,000 | $-595,024,000 |
| Total Unusual Items Excluding Goodwill | $-27,675,000 | $-1,555,727,000 | $46,994,000 | $-595,024,000 |
| Reconciled Depreciation | $448,454,000 | $436,437,000 | $425,786,000 | $415,659,000 |
| EBITDA (Bullshit earnings) | $467,398,000 | $-1,007,904,000 | $651,934,000 | $158,317,000 |
| EBIT | $18,944,000 | $-1,444,341,000 | $226,148,000 | $-257,342,000 |
| Diluted Average Shares | $16,434,919 | $16,147,506 | $16,128,366 | $15,973,142 |
| Basic Average Shares | $16,434,919 | $16,147,506 | $16,128,366 | $15,973,142 |
| Diluted NI Availto Com Stockholders | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Minority Interests | $0 | $0 | $0 | - |
| Tax Provision | $-88,796,000 | $-124,881,000 | $-15,363,000 | $12,169,000 |
| Gain On Sale Of Ppe | $-9,357,000 | $-8,595,000 | $-851,000 | - |
| Other Special Charges | $7,606,000 | $-5,184,000 | $-53,944,000 | $-34,551,000 |
| Impairment Of Capital Assets | $0 | $1,488,863,000 | $0 | $662,221,000 |
| Restructuring And Mergern Acquisition | $8,045,000 | $63,930,000 | $8,064,000 | $34,693,000 |
| Gain On Sale Of Security | $-2,667,000 | $477,000 | $1,965,000 | $67,339,000 |
| Amortization | $343,757,000 | $343,883,000 | $342,694,000 | $340,536,000 |
| Selling General And Administration | $158,562,000 | $86,845,000 | $74,966,000 | $132,144,000 |
| Other Gand A | $132,794,000 | $68,280,000 | $62,480,000 | $120,412,000 |
| Salaries And Wages | $25,768,000 | $18,565,000 | $12,486,000 | $11,732,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,464,357,000 | $-4,545,441,000 | $-4,753,085,000 | $-4,854,858,000 |
| Total Assets | $4,888,458,000 | $5,150,827,000 | $6,964,687,000 | $7,371,104,000 |
| Total Non Current Assets | $4,664,091,000 | $4,975,312,000 | $6,771,094,000 | $6,924,367,000 |
| Other Non Current Assets | $33,342,000 | $37,103,000 | $21,776,000 | $21,895,000 |
| Goodwill And Other Intangible Assets | $4,290,457,000 | $4,629,463,000 | $6,462,209,000 | $6,645,400,000 |
| Other Intangible Assets | $1,884,604,000 | $2,226,323,000 | $2,633,207,000 | $2,940,201,000 |
| Current Assets | $224,367,000 | $175,515,000 | $193,593,000 | $446,737,000 |
| Other Current Assets | $14,330,000 | $6,995,000 | $2,548,000 | $3,676,000 |
| Restricted Cash | $11,527,000 | $12,824,000 | $9,947,000 | $6,513,000 |
| Prepaid Assets | $43,518,000 | $27,240,000 | $24,796,000 | $23,595,000 |
| Receivables | $138,178,000 | $111,608,000 | $84,755,000 | $78,907,000 |
| Other Receivables | $10,563,000 | $21,850,000 | $8,197,000 | - |
| Accounts Receivable | $127,615,000 | $89,758,000 | $76,558,000 | $78,907,000 |
| Allowance For Doubtful Accounts Receivable | $-470,000 | $-448,000 | $-448,000 | $-415,000 |
| Gross Accounts Receivable | $128,085,000 | $90,206,000 | $77,006,000 | $79,322,000 |
| Cash Cash Equivalents And Short Term Investments | $16,814,000 | $16,848,000 | $71,547,000 | $334,046,000 |
| Cash And Cash Equivalents | $16,814,000 | $16,848,000 | $71,547,000 | $334,046,000 |
| Debt | ||||
| Net Debt | $4,578,316,000 | $4,506,127,000 | $4,474,436,000 | $4,421,060,000 |
| Total Debt | $4,616,071,000 | $4,541,217,000 | $4,567,899,000 | $4,782,363,000 |
| Long Term Debt And Capital Lease Obligation | $4,596,676,000 | $4,523,582,000 | $4,549,857,000 | $4,762,750,000 |
| Long Term Debt | $4,580,440,000 | $4,509,725,000 | $4,532,733,000 | $4,741,856,000 |
| Current Debt And Capital Lease Obligation | $19,395,000 | $17,635,000 | $18,042,000 | $19,613,000 |
| Current Debt | $14,690,000 | $13,250,000 | $13,250,000 | $13,250,000 |
| Other Current Borrowings | $14,690,000 | $13,250,000 | $13,250,000 | $13,250,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,055,633,000 | $5,066,805,000 | $5,255,563,000 | $5,580,562,000 |
| Total Non Current Liabilities Net Minority Interest | $4,794,275,000 | $4,853,015,000 | $5,088,824,000 | $5,404,718,000 |
| Non Current Deferred Liabilities | $197,599,000 | $325,834,000 | $521,707,000 | $639,498,000 |
| Non Current Deferred Taxes Liabilities | $197,599,000 | $325,834,000 | $521,707,000 | $639,498,000 |
| Current Liabilities | $261,358,000 | $213,790,000 | $166,739,000 | $175,844,000 |
| Other Current Liabilities | $6,052,000 | $3,115,000 | - | - |
| Payables And Accrued Expenses | $190,673,000 | $159,350,000 | $103,977,000 | $121,663,000 |
| Interest Payable | $100,009,000 | $55,532,000 | $56,827,000 | $57,982,000 |
| Payables | $60,463,000 | $86,327,000 | $19,590,000 | $13,295,000 |
| Accounts Payable | $60,463,000 | $86,327,000 | $19,590,000 | $13,295,000 |
| Other Non Current Liabilities | - | $3,599,000 | $16,783,000 | $28,000 |
| Derivative Product Liabilities | - | $0 | $477,000 | $2,442,000 |
| Total Tax Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-173,900,000 | $84,022,000 | $1,709,124,000 | $1,790,542,000 |
| Total Equity Gross Minority Interest | $-167,175,000 | $84,022,000 | $1,709,124,000 | $1,790,542,000 |
| Stockholders Equity | $-173,900,000 | $84,022,000 | $1,709,124,000 | $1,790,542,000 |
| Gains Losses Not Affecting Retained Earnings | $-4,172,000 | $-5,063,000 | $-11,778,000 | $0 |
| Other Equity Adjustments | $-4,172,000 | $-5,063,000 | $-11,778,000 | - |
| Retained Earnings | $-2,429,420,000 | $-2,145,138,000 | $-499,307,000 | $-347,800,000 |
| Other | ||||
| Treasury Shares Number | $742,859 | $742,859 | $487,222 | $677,935 |
| Ordinary Shares Number | $16,552,723 | $16,187,968 | $16,207,984 | $15,979,323 |
| Share Issued | $17,295,582 | $16,930,827 | $16,695,206 | $16,657,258 |
| Tangible Book Value | $-4,464,357,000 | $-4,545,441,000 | $-4,753,085,000 | $-4,854,858,000 |
| Invested Capital | $4,421,230,000 | $4,606,997,000 | $6,255,107,000 | $6,545,648,000 |
| Working Capital | $-36,991,000 | $-38,275,000 | $26,854,000 | $270,893,000 |
| Capital Lease Obligations | $20,941,000 | $18,242,000 | $21,916,000 | $27,257,000 |
| Total Capitalization | $4,406,540,000 | $4,593,747,000 | $6,241,857,000 | $6,532,398,000 |
| Minority Interest | $6,725,000 | $0 | - | - |
| Treasury Stock | $138,733,000 | $138,733,000 | $128,363,000 | $192,169,000 |
| Additional Paid In Capital | $2,398,423,000 | $2,372,954,000 | $2,348,570,000 | $2,330,444,000 |
| Capital Stock | $2,000 | $2,000 | $2,000 | $67,000 |
| Common Stock | $2,000 | $2,000 | $2,000 | $67,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $16,236,000 | $13,857,000 | $17,124,000 | $20,894,000 |
| Current Capital Lease Obligation | $4,705,000 | $4,385,000 | $4,792,000 | $6,363,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $45,238,000 | $33,690,000 | $44,720,000 | $34,568,000 |
| Current Accrued Expenses | $130,210,000 | $73,023,000 | $84,387,000 | $108,368,000 |
| Goodwill | $2,405,853,000 | $2,403,140,000 | $3,829,002,000 | $3,705,199,000 |
| Net PPE | $340,292,000 | $308,746,000 | $287,109,000 | $257,072,000 |
| Accumulated Depreciation | $-473,460,000 | $-420,427,000 | $-425,388,000 | $-351,446,000 |
| Gross PPE | $813,752,000 | $729,173,000 | $712,497,000 | $608,518,000 |
| Leases | $3,131,000 | $2,465,000 | $4,116,000 | $4,115,000 |
| Other Properties | $13,966,000 | $16,097,000 | $19,680,000 | $24,237,000 |
| Machinery Furniture Equipment | $796,655,000 | $710,611,000 | $688,701,000 | $580,166,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-12,277,000 | $-10,507,000 | $62,868,000 | $282,629,000 |
| Operating Activities | ||||
| Operating Cash Flow | $117,324,000 | $107,616,000 | $171,720,000 | $372,364,000 |
| Cash Flow From Continuing Operating Activities | $117,324,000 | $107,616,000 | $171,720,000 | $372,364,000 |
| Operating Gains Losses | $12,694,000 | $2,205,000 | $-55,082,000 | $-100,839,000 |
| Investing Activities | ||||
| Capital Expenditure | $-129,601,000 | $-118,123,000 | $-108,852,000 | $-89,735,000 |
| Investing Cash Flow | $-121,018,000 | $-118,123,000 | $-249,792,000 | $-104,446,000 |
| Cash Flow From Continuing Investing Activities | $-121,018,000 | $-118,123,000 | $-249,792,000 | $-104,446,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-10,370,000 | $-15,218,000 | $0 |
| Financing Cash Flow | $2,363,000 | $-41,315,000 | $-180,993,000 | $-115,738,000 |
| Cash Flow From Continuing Financing Activities | $2,363,000 | $-41,315,000 | $-180,993,000 | $-115,738,000 |
| Net Other Financing Charges | $-8,362,000 | $-3,971,000 | $-465,000 | $-2,463,000 |
| Net Common Stock Issuance | $0 | $-10,370,000 | $-15,218,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-221,017,000 | $-28,136,000 | $-165,788,000 | $-113,249,000 |
| Issuance Of Debt | $230,000,000 | $0 | $0 | $0 |
| Interest Paid Supplemental Data | $282,755,000 | $315,245,000 | $323,396,000 | $289,766,000 |
| Income Tax Paid Supplemental Data | $44,495,000 | $80,089,000 | $100,083,000 | $124,082,000 |
| End Cash Position | $28,341,000 | $29,672,000 | $81,494,000 | $340,559,000 |
| Beginning Cash Position | $29,672,000 | $81,494,000 | $340,559,000 | $188,379,000 |
| Changes In Cash | $-1,331,000 | $-51,822,000 | $-259,065,000 | $152,180,000 |
| Proceeds From Stock Option Exercised | $1,742,000 | $1,095,000 | $508,000 | $0 |
| Common Stock Payments | $0 | $-10,370,000 | $-15,218,000 | $0 |
| Net Issuance Payments Of Debt | $8,983,000 | $-28,069,000 | $-165,818,000 | $-113,275,000 |
| Net Long Term Debt Issuance | $8,983,000 | $-28,069,000 | $-165,818,000 | $-113,275,000 |
| Long Term Debt Payments | $-221,017,000 | $-28,136,000 | $-165,788,000 | $-113,249,000 |
| Long Term Debt Issuance | $230,000,000 | $0 | $0 | $0 |
| Net Investment Purchase And Sale | $13,333,000 | $0 | $0 | $289,000 |
| Sale Of Investment | $13,333,000 | $0 | $0 | $289,000 |
| Net Business Purchase And Sale | $-4,750,000 | $0 | $-140,940,000 | $-15,000,000 |
| Purchase Of Business | $-4,750,000 | $0 | $-140,940,000 | $-15,000,000 |
| Net PPE Purchase And Sale | $-129,601,000 | $-118,123,000 | $-108,852,000 | $-89,735,000 |
| Purchase Of PPE | $-129,601,000 | $-118,123,000 | $-108,852,000 | $-89,735,000 |
| Change In Working Capital | $-28,866,000 | $-14,398,000 | $-21,932,000 | $55,335,000 |
| Change In Other Current Liabilities | $-5,134,000 | $-6,270,000 | $-6,625,000 | $-6,520,000 |
| Change In Payables And Accrued Expense | $31,581,000 | $42,216,000 | $-13,081,000 | $34,349,000 |
| Change In Accrued Expense | $57,445,000 | $-25,136,000 | $-18,659,000 | - |
| Change In Payable | $-25,864,000 | $67,352,000 | $5,578,000 | $34,349,000 |
| Change In Account Payable | $-25,864,000 | $67,352,000 | $5,578,000 | $34,349,000 |
| Change In Prepaid Assets | $-28,743,000 | $-37,144,000 | $-6,628,000 | $6,508,000 |
| Change In Receivables | $-26,570,000 | $-13,200,000 | $4,402,000 | $20,998,000 |
| Changes In Account Receivables | $-26,570,000 | $-13,200,000 | $4,402,000 | $20,998,000 |
| Other Non Cash Items | $70,010,000 | $11,703,000 | $10,687,000 | $10,539,000 |
| Stock Based Compensation | $27,822,000 | $26,645,000 | $18,018,000 | $16,739,000 |
| Asset Impairment Charge | $0 | $1,488,863,000 | $0 | $662,221,000 |
| Deferred Tax | $-128,508,000 | $-198,008,000 | $-114,060,000 | $-114,378,000 |
| Deferred Income Tax | $-128,508,000 | $-198,008,000 | $-114,060,000 | $-114,378,000 |
| Depreciation Amortization Depletion | $448,454,000 | $436,437,000 | $425,786,000 | $415,659,000 |
| Depreciation And Amortization | $448,454,000 | $436,437,000 | $425,786,000 | $415,659,000 |
| Amortization Cash Flow | $343,757,000 | $343,883,000 | $342,694,000 | $340,536,000 |
| Amortization Of Intangibles | $343,757,000 | $343,883,000 | $342,694,000 | $340,536,000 |
| Depreciation | $104,697,000 | $92,554,000 | $83,092,000 | $75,123,000 |
| Gain Loss On Investment Securities | $2,667,000 | $-477,000 | $-1,965,000 | $-67,339,000 |
| Net Income From Continuing Operations | $-284,282,000 | $-1,645,831,000 | $-91,697,000 | $-572,912,000 |
| Gain Loss On Sale Of PPE | - | $8,595,000 | $851,000 | $1,051,000 |
| Sale Of Business | - | - | $0 | $0 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-18